Semaglutide, marketed under the brand names Ozempic, Wegovy, and Rybelsus, is a GLP-1 agonist available in various forms, including weekly injections (Ozempic for diabetes and Wegovy for obesity) and daily oral tablets (Rybelsus)
476,508 Total views 380,007 Article views 93,259 Article downloads 3,242 Topic views About Frontiers Research Topics With their unique mixes of varied contributions from Original Research to Review Articles, Research Topics unify the most influential researchers, the latest key findings and historical advances in a hot research area
There are exceptions, but for hair growth, oral peptide products generally do not produce the same clinical response as topical-plus-microneedling or injectable protocols
While some nutrients like omega-3 fatty acids and B vitamins are involved in neurological function, evidence for their direct mood-stabilizing effects is mixed, and a balanced diet is the primary recommendation
There are no known direct drug interactions between semaglutide and caffeine listed in the British National Formulary (BNF) or the product's SmPC, and patients are not routinely advised to avoid caffeinated beverages such as tea, coffee, or cola drinks
Because of reports like these, regulators have investigated whether GLP-1 drugs may be linked to depression or suicidal thoughts
